Artículos por temáticas

Bioavailable testosterone predicts a lower risk of Alzheimer's disease in older men

Chu LW, Tam S, Wong RL, Yik PY, Song Y, Cheung BM, Morley JE, Lam KS.

J Alzheimers Dis. 2010;21(4):1335-45. doi: 10.3233/jad-2010-100027.

Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?

Krautwald M, Münch G.

Exp Gerontol. 2010 Oct;45(10):744-51. doi: 10.1016/j.exger.2010.03.001. Epub 2010 Mar 6.

Aspirin in Alzheimer's disease: increased risk of intracerebral hemorrhage: cause for concern?

Thoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, Van Gool WA, Nederkoorn PJ.

Stroke. 2010 Nov;41(11):2690-2. doi: 10.1161/STROKEAHA.109.576975. Epub 2010 Oct 7.

A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors

Jones RW.

Int J Geriatr Psychiatry. 2010 Jun;25(6):547-53. doi: 10.1002/gps.2384.

Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention

Qiu C, Xu W, Fratiglioni L.

J Alzheimers Dis. 2010;20(3):689-97. doi: 10.3233/JAD-2010-091663.

Reviews: developing culturally sensitive dementia caregiver interventions: are we there yet?

Napoles AM, Chadiha L, Eversley R, Moreno-John G.

Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):389-406. doi: 10.1177/1533317510370957. Epub 2010 May 27.

The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease

Yu CE, Marchani E, Nikisch G, Müller U, Nolte D, Hertel A, Wijsman EM, Bird TD.

Arch Neurol. 2010 May;67(5):631-3. doi: 10.1001/archneurol.2010.87.

Prion protein is reduced in aging and in sporadic but not in familial Alzheimer's disease

Whitehouse IJ, Jackson C, Turner AJ, Hooper NM.

J Alzheimers Dis. 2010;22(3):1023-31. doi: 10.3233/JAD-2010-101071.

The accuracy of short clinical rating scales in neuropathologically diagnosed dementia

Gustafson L, Englund E, Brunnström H, Brun A, Erikson C, Warkentin S, Passant U.

Am J Geriatr Psychiatry. 2010 Sep;18(9):810-20. doi: 10.1097/JGP.0b013e3181cdef7a.

Cardiac disorders as risk factors for Alzheimer's disease

de Toledo Ferraz Alves TC, Ferreira LK, Wajngarten M, Busatto GF.

J Alzheimers Dis. 2010;20(3):749-63. doi: 10.3233/JAD-2010-091561.

Epileptic seizures in AD patients

Larner AJ.

Neuromolecular Med. 2010 Mar;12(1):71-7. doi: 10.1007/s12017-009-8076-z. Epub 2009 Jun 26.

Learning to perceive structure from motion and neural plasticity in patients with Alzheimer's disease

Kim NG, Park JH.

Neuropsychologia. 2010 Apr;48(5):1464-71. doi: 10.1016/j.neuropsychologia.2010.01.016. Epub 2010 Jan 29.

Alzheimer's Disease Neuroimaging Initiative special issue

Frisoni GB, Weiner MW.

Neurobiol Aging. 2010 Aug;31(8):1259-62. doi: 10.1016/j.neurobiolaging.2010.05.006. Epub 2010 Jun 8.

Prospective one-year cost-of-illness study in a cohort of patients with dementia of Alzheimer's disease type in Spain: the ECO study

Coduras A, Rabasa I, Frank A, Bermejo-Pareja F, López-Pousa S, López-Arrieta JM, Del Llano J, León T, Rejas J.

J Alzheimers Dis. 2010;19(2):601-15. doi: 10.3233/JAD-2010-1258.

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, Sekita A, Suzuki SO, Kanba S, Kiyohara Y, Iwaki T.

Neurology. 2010 Aug 31;75(9):764-70. doi: 10.1212/WNL.0b013e3181eee25f. Epub 2010 Aug 25.